Lilly heeds Trump to spend $400m on US manufacturing network
In addition to the capital investment to expand insulin manufacturing capabilities, the company will also create 100 jobs in the country.
In addition to the capital investment to expand insulin manufacturing capabilities, the company will also create 100 jobs in the country.
Editas Medicine points to AskBio’s ‘excellent manufacturing facility’ and associated expertise to explain benefits of recent partnership.